Literature DB >> 19172304

Modesty and recognition--a qualitative study of the lived experience of recovery from anal cancer.

Julie Midtgaard1, Mette Juel Hansen, Birgitte Grandjean.   

Abstract

BACKGROUND: Anal cancer is a rare disease within the cancer spectrum. Long-term disabilities are notable and place increased demands on rehabilitation. AIM: The objective of this study was to describe the lived experiences of recovery from anal cancer, including which and how resources may help survivors of anal cancer to resist and to manage potentially complex stressors encountered in the recovery from the disease.
DESIGN: A qualitative, salutogenetic-oriented, phenomenological study was conducted based on audio-taped, semi-structured interviews.
METHODS: Interviewee selection was carried out through purposeful sampling. Sixteen individuals (11 women and five men; average age 52 years), who had completed therapy for anal cancer (average 31 months ago), participated in the study. Transcripts from the audio-taped interviews were used for qualitative text condensation analysis, inspired by Giorgi's phenomenological methodology.
FINDINGS: The analysis revealed two concepts, modesty and recognition, which describe the essence of the lived experience of anal cancer, and which each appear to be important resistance resources. While modesty is regarded as an enforced and necessary competence developed and mastered by the individual, recognition refers to a desired, but often lacking, resource in the individual's interaction with health authorities and relatives. DISCUSSION: Anal cancer appears to lack attention and deserved recognition from professional and social services, which in itself may lead to mistrust and devaluation of the individual seeking support. It is recommended that both researchers and rehabilitation services incorporate, prioritize, and advise on the disease's specific issues and the terms under which the survivor can maintain an active, working and social life, as desired.

Entities:  

Mesh:

Year:  2009        PMID: 19172304     DOI: 10.1007/s00520-008-0576-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  16 in total

1.  Qualitative research: standards, challenges, and guidelines.

Authors:  K Malterud
Journal:  Lancet       Date:  2001-08-11       Impact factor: 79.321

Review 2.  An introduction to quality of life assessment in oncology: the value of measuring patient-reported outcomes.

Authors:  Carolyn E Schwartz; Mirjam A G Sprangers
Journal:  Am J Manag Care       Date:  2002-12       Impact factor: 2.229

Review 3.  Salutogenesis.

Authors:  Bengt Lindström; Monica Eriksson
Journal:  J Epidemiol Community Health       Date:  2005-06       Impact factor: 3.710

4.  The disability paradox: high quality of life against all odds.

Authors:  G L Albrecht; P J Devlieger
Journal:  Soc Sci Med       Date:  1999-04       Impact factor: 4.634

5.  Faecal incontinence: A late side-effect of pelvic radiotherapy.

Authors:  S Putta; H J N Andreyev
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-09       Impact factor: 4.126

Review 6.  A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery.

Authors:  L Desnoo; S Faithfull
Journal:  Eur J Cancer Care (Engl)       Date:  2006-07       Impact factor: 2.520

7.  Shared understanding of the qualitative research process. Guidelines for the medical researcher.

Authors:  K Malterud
Journal:  Fam Pract       Date:  1993-06       Impact factor: 2.267

8.  Users' guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  M K Giacomini; D J Cook
Journal:  JAMA       Date:  2000-07-19       Impact factor: 56.272

9.  Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors.

Authors:  C R Jephcott; C Paltiel; J Hay
Journal:  Clin Oncol (R Coll Radiol)       Date:  2004-12       Impact factor: 4.126

10.  Contextualizing salutogenesis and Antonovsky in public health development.

Authors:  Bengt Lindström; Monica Eriksson
Journal:  Health Promot Int       Date:  2006-05-22       Impact factor: 2.483

View more
  4 in total

1.  Development and use of new therapeutics for rare diseases: views from patients, caregivers, and advocates.

Authors:  Aaron S Kesselheim; Sarah McGraw; Lauren Thompson; Kelly O'Keefe; Joshua J Gagne
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

2.  Supporting the Return to Work After Cancer in Romania: Exploring Employers' Perspectives.

Authors:  Adela Elena Popa; Felicia Morândău; Radu-Ioan Popa; Mihai Stelian Rusu; Alexandra Sidor
Journal:  J Occup Rehabil       Date:  2020-03

3.  How do women with lupus manage fatigue? A focus group study.

Authors:  Anne Ørnholt Kier; Julie Midtgaard; Karin Sørig Hougaard; Anja Berggreen; Gunhild Bukh; Renata Baronaite Hansen; Lene Dreyer
Journal:  Clin Rheumatol       Date:  2016-05-25       Impact factor: 2.980

4.  Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey.

Authors:  Eline de Heus; Vivian Engelen; Irene Dingemans; Carol Richel; Marga Schrieks; Jan Maarten van der Zwan; Marc G Besselink; Mark I van Berge Henegouwen; Carla M L van Herpen; Saskia F A Duijts
Journal:  Orphanet J Rare Dis       Date:  2021-06-01       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.